Literature DB >> 29341460

Intellectual disability and epilepsy due to the K/L-mediated Xq28 duplication: Further evidence of a distinct, dosage-dependent phenotype.

David Isum Ward1, Bethany A Buckley1, Eyby Leon2, Jullianne Diaz2, Margaret Faust Galegos2, Sean Hofherr2, Amy Feldman Lewanda1,2.   

Abstract

Copy number variants of the X-chromosome are a common cause of X-linked intellectual disability in males. Duplication of the Xq28 band has been known for over a decade to be the cause of the Lubs X-linked Mental Retardation Syndrome (OMIM 300620) in males and this duplication has been narrowed to a critical region containing only the genes MECP2 and IRAK1. In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated "K" and "L" were reported with intellectual disability and epilepsy. Duplication of a second more distal region has been described as the cause of the Int22h-1/Int22h-2 Mediated Xq28 Duplication Syndrome, characterized by intellectual disability, psychiatric problems, and recurrent infections. We report two additional families possessing the K/L-mediated Xq28 duplication with affected males having intellectual disability and epilepsy similar to the previously reported phenotype. To our knowledge, this is the second cohort of individuals to be reported with this duplication and therefore supports K/L-mediated Xq28 duplications as a distinct syndrome.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GDI1; X chromosome duplication; Xq28 duplication; mental retardation; x-linked

Mesh:

Substances:

Year:  2018        PMID: 29341460      PMCID: PMC6679916          DOI: 10.1002/ajmg.a.38524

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  32 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome.

Authors:  M Meins; J Lehmann; F Gerresheim; J Herchenbach; M Hagedorn; K Hameister; J T Epplen
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

3.  Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections.

Authors:  M Smyk; E Obersztyn; B Nowakowska; M Nawara; S W Cheung; T Mazurczak; P Stankiewicz; E Bocian
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

4.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

Authors:  Hilde Van Esch; Marijke Bauters; Jaakko Ignatius; Mieke Jansen; Martine Raynaud; Karen Hollanders; Dorien Lugtenberg; Thierry Bienvenu; Lars Riff Jensen; Jozef Gecz; Claude Moraine; Peter Marynen; Jean-Pierre Fryns; Guy Froyen
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

5.  Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH.

Authors:  D Lugtenberg; A P M de Brouwer; T Kleefstra; A R Oudakker; S G M Frints; C T R M Schrander-Stumpel; J P Fryns; L R Jensen; J Chelly; C Moraine; G Turner; J A Veltman; B C J Hamel; B B A de Vries; H van Bokhoven; H G Yntema
Journal:  J Med Genet       Date:  2005-09-16       Impact factor: 6.318

6.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

7.  Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.

Authors:  Ann L Collins; Jonathan M Levenson; Alexander P Vilaythong; Ronald Richman; Dawna L Armstrong; Jeffrey L Noebels; J David Sweatt; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2004-09-06       Impact factor: 6.150

8.  Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.

Authors:  Sandra Luikenhuis; Emanuela Giacometti; Caroline F Beard; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

9.  Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training.

Authors:  Veronica Bianchi; Pasqualina Farisello; Pietro Baldelli; Virginia Meskenaite; Marco Milanese; Matteo Vecellio; Sven Mühlemann; Hans Peter Lipp; Giambattista Bonanno; Fabio Benfenati; Daniela Toniolo; Patrizia D'Adamo
Journal:  Hum Mol Genet       Date:  2008-10-01       Impact factor: 6.150

10.  Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males.

Authors:  Daniela del Gaudio; Ping Fang; Fernando Scaglia; Patricia A Ward; William J Craigen; Daniel G Glaze; Jeffrey L Neul; Ankita Patel; Jennifer A Lee; Mira Irons; Susan A Berry; Amber A Pursley; Theresa A Grebe; Debra Freedenberg; Rick A Martin; Gary E Hsich; Jena R Khera; Neil R Friedman; Huda Y Zoghbi; Christine M Eng; James R Lupski; Arthur L Beaudet; Sau Wai Cheung; Benjamin B Roa
Journal:  Genet Med       Date:  2006-12       Impact factor: 8.822

View more
  1 in total

1.  Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndrome.

Authors:  Smita Jagtap; Jessica M Thanos; Ting Fu; Jennifer Wang; Jasmin Lalonde; Thomas O Dial; Ariel Feiglin; Jeffrey Chen; Isaac Kohane; Jeannie T Lee; Steven D Sheridan; Roy H Perlis
Journal:  Hum Mol Genet       Date:  2019-11-01       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.